Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,864,801 papers from all fields of science
Search
Sign In
Create Free Account
TP53BP1 wt Allele
Known as:
53BP1
, FLJ41424
, MGC138366
Expand
Human TP53BP1 wild-type allele is located within 15q15-q21 and is approximately 103 kb in length. This allele, which encodes tumor suppressor p53…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Cell Cycle Control
DNA Repair
Broader (1)
TP53BP1 gene
Narrower (1)
TP53BP1 protein, human
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Induction of p202, a modulator of apoptosis, during oncogenic transformation of NIH 3T3 cells by activated H‐Ras (Q61L) contributes to cell survival
H. Xin
,
Y. Geng
,
R. Pramanik
,
D. Choubey
Journal of Cellular Biochemistry
2003
Corpus ID: 23509836
Previous studies have revealed that p202 (52 kDa), an interferon (IFN) and differentiation‐inducible protein, negatively…
Expand
Review
2002
Review
2002
Interferon-inducible p202 in the susceptibility to systemic lupus.
D. Choubey
,
B. Kotzin
Frontiers in Bioscience
2002
Corpus ID: 19054144
Systemic lupus erythematosus (SLE) is the prototype systemic autoimmune disease, which has potential to involve multiple organ…
Expand
2001
2001
p202, an interferon-inducible protein, mediates multiple antitumor activities in human pancreatic cancer xenograft models.
Y. Wen
,
D. Yan
,
+6 authors
M. Hung
Cancer Research
2001
Corpus ID: 17949737
p202, an IFN-inducible protein, interacts with certain transcriptional activators leading to transcriptional repression. p202…
Expand
Review
2000
Review
2000
P202: an interferon-inducible negative regulator of cell growth.
D. Choubey
Journal of Biological Regulators and Homeostatic…
2000
Corpus ID: 32861464
2000
2000
Tumor suppression and sensitization to tumor necrosis factor alpha-induced apoptosis by an interferon-inducible protein, p202, in breast cancer cells.
Y. Wen
,
D. Yan
,
B. Spohn
,
J. Deng
,
S. Lin
,
M. Hung
Cancer Research
2000
Corpus ID: 23460452
p202, an IFN-inducible protein, interacts with several important regulatory proteins, leading to growth arrest or differentiation…
Expand
1999
1999
Retardation of cell proliferation after expression of p202 accompanies an increase in p21(WAF1/CIP1).
J. Gutterman
,
D. Choubey
Cell growth & differentiation : the molecular…
1999
Corpus ID: 9753514
p202 is an IFN-inducible, primarily nuclear, phosphoprotein (52-kDa) whose constitutive overexpression in transfected cells…
Expand
1999
1999
Reduced growth rate and transformation phenotype of the prostate cancer cells by an interferon-inducible protein, p202
D. Yan
,
Y. Wen
,
B. Spohn
,
D. Choubey
,
J. Gutterman
,
M. Hung
Oncogene
1999
Corpus ID: 37415597
Interferons (IFNs) can exert cytostatic and immunomodulatory effects on carcinoma cells. In particular, growth inhibition of…
Expand
Highly Cited
1998
Highly Cited
1998
Increase in p202 Expression during Skeletal Muscle Differentiation: Inhibition of MyoD Protein Expression and Activity by p202
B. Datta
,
W. Min
,
S. Burma
,
P. Lengyel
Molecular and Cellular Biology
1998
Corpus ID: 1199494
ABSTRACT p202 is a primarily nuclear, interferon-inducible murine protein that is encoded by the Ifi 202 gene. Overexpression of…
Expand
1998
1998
p202 self‐associates through a sequence conserved among the members of the 200‐family proteins
D. Koul
,
Nihal U Obeyesekere
,
J. Gutterman
,
G. Mills
,
D. Choubey
FEBS Letters
1998
Corpus ID: 27803720
Highly Cited
1997
Highly Cited
1997
Inhibition of E2F-4/DP-1-stimulated transcription by p202
D. Choubey
,
J. Gutterman
Oncogene
1997
Corpus ID: 9444922
The interferon (IFN)-inducible proteins mediate activities of the interferons including the cell growth-regulatory activity. We…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE